Скачать или смотреть ImmunityBio IBRX Surges After Two Saudi FDA Approvals

IBRX Surges After Two Saudi FDA Approvals

I use Interactive Brokers to buy most of the stocks I talk about. Create an account and get FREE stocks here: https://ibkr.com/referral/olivier574

Disclaimer
This video is for educational and entertainment purposes only and is not investment advice. I am purely documenting my opinions on companies that interest me. I am not a Financial Advisor and I am not your Financial Advisor. You risk losing your money by investing. Please do your own due diligence and get advice from an expert. I am human and get things wrong.

Tags
IBRX, ImmunityBio, Immunity Bio, Immunity Bio stock, ImmunityBio stock, IBRX stock, IBRX stock analysis, IBRX news, IBRX stock today, IBRX stock prediction, IBRX stock 2026, biotech stocks, biotech investing, cancer biotech stocks, immunotherapy stocks, ANKTIVA, ANKTIVA approval, ANKTIVA bladder cancer, ANKTIVA lung cancer, non muscle invasive bladder cancer, NMIBC, NSCLC immunotherapy, checkpoint inhibitor combination, Saudi FDA approval, Saudi Arabia biotech, Saudi healthcare investment, Saudi FDA accelerated approval, Middle East biotech, first in world approval, international drug approval, Patrick Soon Shiong, billionaire investor stocks, billionaire biotech, insider ownership stocks, founder led biotech, healthcare billionaire, smart money biotech, small cap stocks, high growth stocks, exploding stocks, stocks under $10, stocks under $5, stock catalysts, biotech stock catalyst, stock market rally, Invest with Olivier, stock market analysis, long term investing, growth investing, asymmetric investing